Sterling Winthrop
Executive Summary
Licenses Feridex liver cancer magnetic resonance imaging agent from Advanced Magnetics. Under the agreement announced Sept. 28, Sterling will make payments of up to $7.75 mil. in exchange for marketing rights in the U.S., Canada, Mexico and Australia. Sterling's Sanofi Winthrop will market product. Advanced Magnetics says it plans to file an NDA for the contrast agent by March 1994. The Cambridge, Mass.-based firm will receive royalties on sales of Feridex and payment for the supply of the product to Sterling.